Cerity Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241K Buy
+11,729
New +$269K ﹤0.01% 2945
2024
Q4
– Sell
-13,619
Closed -$277K – 2453
2024
Q3
$277K Buy
+13,619
New +$278K ﹤0.01% 2112
2024
Q2
– Sell
-8,756
Closed -$230K – 2255
2024
Q1
$230K Sell
8,756
-61,939
-88% -$1.76M ﹤0.01% 2027
2023
Q4
$2.23M Buy
+70,695
New +$1.92M 0.01% 742
2023
Q3
– Sell
-72,297
Closed -$2.67M – 1432
2023
Q2
$2.67M Sell
72,297
-35
-0% -$1.07K 0.01% 650
2023
Q1
$2.17M Buy
+72,332
New +$2.38M 0.01% 704

Other funds holding CC

Cerity Partners's CC Position: Q2 2026 in Review

Cerity Partners opened a new position in Chemours (CC) in Q2 2026: 11,729 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #2945 among its holdings. This is a return to the name: Cerity Partners previously reported a position in CC as recently as Q3 2024.

Cerity Partners first reported a position in CC in Q1 2023 and has held it in 6 quarters since. The position peaked at $2.67M in Q2 2023. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Cerity Partners held 11,729 shares of Chemours worth $241K as of Q2 2026.
  • Chemours was a new Cerity Partners position in Q2 2026.
  • Chemours made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2945 holding.
  • Cerity Partners first reported a position in Chemours in Q1 2023 and has held it in 6 quarters since.
  • Cerity Partners's Chemours position peaked at $2.67M in Q2 2023.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.